Biological evaluation of 2′-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (2) , 291-295
- https://doi.org/10.1016/j.nucmedbio.2003.09.003
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Radiosynthesis of 3-(2′-[18F]fluoro)-flumazenil ([18F]FFMZ)Journal of Labelled Compounds and Radiopharmaceuticals, 2003
- In vivo and in vitro evaluation of [ 18 F]FETO with respect to the adrenocortical and GABAergic system in ratsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Novel one-pot one-step synthesis of 2′-[18F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imagingPublished by Elsevier ,2003
- Synthesis of [18F]FETO, a novel potential 11‐β hydroxylase inhibitorJournal of Labelled Compounds and Radiopharmaceuticals, 2003
- New insights into the role of the GABAA–benzodiazepine receptor in psychiatric disorderThe British Journal of Psychiatry, 2001
- Structure and subunit composition of GABAA receptorsNeurochemistry International, 1999
- The benzodiazepine binding site of GABAA receptorsTrends in Pharmacological Sciences, 1997
- Flumazenil attenuates the pituitary response to CRH in healthy malesEuropean Neuropsychopharmacology, 1996
- Binding of 5-(2′-[18F]fluoroenthyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomographyEuropean Journal of Pharmacology, 1992
- Synthesis of ethyl 8-fluoro-5,6-dihydro5- [11C]methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): A specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomographyThe International Journal of Applied Radiation and Isotopes, 1984